# Empiric Quinidine for Asymptomatic Brugada Syndrome

> **NCT00789165** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **International Registry of Asymptomatic Brugada Syndrome**

## Conditions studied

- Arrhythmia

## Interventions

- **DRUG:** quinidine
- **DRUG:** no therapy

## Key facts

- **NCT ID:** NCT00789165
- **Lead sponsor:** International Registry of Asymptomatic Brugada Syndrome
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-12
- **Primary completion:** 2020-02
- **Final completion:** 2020-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2020-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00789165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00789165, "Empiric Quinidine for Asymptomatic Brugada Syndrome". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00789165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*